Novel drug delivery approaches for the management of hair loss

References

• Strazzulla LC, Wang EHC, Avila L, et al. Alopecia areata: an appraisal of new treatment approaches and overview of current therapies. J Am Acad Dermatol. Internet. 2018;78:15–24. DOI:10.1016/j.jaad.2017.04.1142
   PubMed Web of Science ®Google Scholar
• Almohanna HM, Perper M, Tosti A. Safety concerns when using novel medications to treat alopecia. Expert Opin Drug Saf. Internet. 2018;17:1115–1128. DOI:10.1080/14740338.2018.1533549
   PubMed Web of Science ®Google Scholar
• Wipf A, Boysen N, Hordinsky MK, et al. The rise of transcutaneous drug delivery for the management of alopecia: a review of existing literature and an eye towards the future. J Cosmet Laser Ther. Internet. 2019:21:247–254. DOI:10.1080/14764172.2018.1525743
   PubMed Web of Science ®Google Scholar
• Azagury A, Khoury L, Enden G, et al. Ultrasound mediated transdermal drug delivery. Adv Drug Deliv Rev. Internet. 2014;72:127–143. DOI:10.1016/j.addr.2014.01.007
   PubMed Web of Science ®Google Scholar
• Lavon I, Kost J. Ultrasound and transdermal drug delivery. Drug Discov Today. 2004;9:670–676.
   PubMed Web of Science ®Google Scholar
• Arshdeep S, Kumaran M. Platelet-rich plasma in dermatology: boon or a bane? Indian. J Dermatol Venereol Leprol. 2014;80:5–14.
   PubMed Web of Science ®Google Scholar
• Mysore V, Chandrashekar B, Yepuri V. Alopecia areata-successful outcome with microneedling and triamcinolone acetonide. J Cutan Aesthet Surg. 2014;7:63.
   PubMedGoogle Scholar
• Ita K. Transdermal delivery of drugs with microneedles—potential and challenges. Pharmaceutics. 2015;7:90–105.
   PubMed Web of Science ®Google Scholar
• Nalluri BN, Sai Sri V, Anusha SR, et al. In vitro skin permeation enhancement of sumatriptan by microneedle application. Curr Drug Deliv. 2015;12:761.
   PubMed Web of Science ®Google Scholar
• Jha AK, Vinay K, Zeeshan M, et al. Platelet-rich plasma and microneedling improves hair growth in patients of androgenetic alopecia when used as an adjuvant to minoxidil. J Cosmet Dermatol. 2019;18:1–6.
   Web of Science ®Google Scholar
• Moftah N, Moftah N, Abd-Elaziz G, et al. Mesotherapy using dutasteride-containing preparation in treatment of female pattern hair loss: photographic, morphometric and ultrustructural evaluation. J Eur Acad DermatolVenereol. 2013;27:686–693.
   PubMed Web of Science ®Google Scholar
• Melo DF, de Mattos Barreto T, Plata GT, et al. Excellent response to mesotherapy as adjunctive treatment in male androgenetic alopecia. J Cosmet Dermatol. 2019;19:1–3.
   Web of Science ®Google Scholar
• Contin LA. Alopecia androgenética masculina tratada com microagulhamento isolado e associado a minoxidil injetável pela técnica de microinfusão de medicamentos pela pele. Surg Cosmet Dermatol. 2016;8:158–161.
   Google Scholar
• Lahiji SF, Dangol M, Jung H. A patchless dissolving microneedle delivery system enabling rapid and efficient transdermal drug delivery. Sci Rep. 2015;5:1–7.
   Web of Science ®Google Scholar
• Lee C, Yang H, Kim S, et al. Evaluation of the anti-wrinkle effect of an ascorbic acid-loaded dissolving microneedle patch via a double-blind, placebo-controlled clinical study. Int J Cosmet Sci. 2016;38:375–381.
   PubMed Web of Science ®Google Scholar
• Misery L, Erfan N, Castela E, et al. Successful treatment of refractory neuropathic pruritus with capsaicin 8% patch: A bicentric retrospective study with long-term follow-up. Acta Derm Venereol. 2015;95:864–865.
   PubMed Web of Science ®Google Scholar
• Bhusari P, Shukla J, Kumar M, et al. Noninvasive treatment of keloid using customized Re-188 skin patch. Dermatol Ther. 2017;30:1–4.
   Web of Science ®Google Scholar
• Fakhraei Lahiji S, Seo SH, Kim S, et al. Transcutaneous implantation of valproic acid-encapsulated dissolving microneedles induces hair regrowth. Biomaterials. Internet. 2018:167:69–79. DOI:10.1016/j.biomaterials.2018.03.019
   PubMed Web of Science ®Google Scholar
• Dabek RJ, Austen WG, Bojovic B. Laser-assisted Hair Regrowth. Plast Reconstr Surg - Glob Open. 2019;7:e2157.
   PubMedGoogle Scholar
• Yu AJ, Luo YJ, Xu XG, et al. A pilot split-scalp study of combined fractional radiofrequency microneedling and 5% topical minoxidil in treating male pattern hair loss. Clin Exp Dermatol. 2018;43:775–781.
   PubMed Web of Science ®Google Scholar
• Bin CS, Zheng Z, Kang J-S, et al. Therapeutic efficacy of 1,927-nm fractionated thulium laser energy and polydeoxyribonucleotide on pattern hair loss. Med Lasers. 2016;5:22–28.
   Google Scholar
• Cho SB, Goo BL, Zheng Z, et al. Therapeutic efficacy and safety of a 1927-nm fractionated thulium laser on pattern hair loss: an evaluator-blinded, split-scalp study. Lasers Med Sci. 2018;33(4):851–859. DOI:10.1007/s10103-018-2437-5
   PubMed Web of Science ®Google Scholar
• Bertin ACJ, Vilarinho A, Junqueira ALA. Fractional non-ablative laser-assisted drug delivery leads to improvement in male and female pattern hair loss. J Cosmet Laser Ther. 2018;20:391–394.
   PubMed Web of Science ®Google Scholar
• Ke J, Guan H, Li S, et al. Erbium: YAG laser (2,940 nm) treatment stimulates hair growth through upregulating Wnt 10b and β-catenin expression in C57BL/6 mice. Int J Clin Exp Med. 2015;8:20883–20889.
   PubMed Web of Science ®Google Scholar
• Mitragotri S, Blankschtein D, Langer R. Transdermal drug delivery using low-frequency sonophoresis. Pharm Res. 1996;13:411–420.
   PubMed Web of Science ®Google Scholar
• Santoianni P, Nino M, Calabro G. Intradermal drug delivery by low-frequency sonophoresis (25 kHz). Dermatol Online J. 2004;10:24.
   PubMedGoogle Scholar
• Watanabe S, Takagi S, Ga K, et al. Enhanced transdermal drug penetration by the simultaneous application of iontophoresis and sonophoresis. J Drug Deliv Sci Technol. 2009;19:185–189.
   Web of Science ®Google Scholar
• Polat BE, Blankschtein D, Langer R. Low-frequency sonophoresis: application to the transdermal delivery of macromolecules and hydrophilic drugs. Expert Opin Drug Deliv. 2010;7:1415–1432.
   PubMed Web of Science ®Google Scholar
• Gelfuso GM, Gratieri T, Delgado-Charro MB, et al. Iontophoresis-targeted, follicular delivery of minoxidil sulfate for the treatment of alopecia. J Pharm Sci. Internet. 2013;102:1488–1494.
   PubMed Web of Science ®Google Scholar
• Patzelt A, Richter H, Knorr F, et al. Selective follicular targeting by modification of the particle sizes. J Control Release. Internet. 2011;150:45–48. DOI:10.1016/j.jconrel.2010.11.015
   PubMed Web of Science ®Google Scholar
• Papakostas D, Rancan F, Sterry W, et al. Nanoparticles in dermatology. Arch Dermatol Res. 2011;303:533–550.
   PubMed Web of Science ®Google Scholar
• Jung S, Otberg N, Thiede G, et al. Innovative liposomes as a transfollicular drug delivery system: penetration into porcine hair follicles. J Invest Dermatol. 2006;126:1728–1732.
   PubMed Web of Science ®Google Scholar
• Das S, Ng WK, Tan RBH. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs? Eur J Pharm Sci. 2012;47:139–151.
   PubMed Web of Science ®Google Scholar
• Roque LV, Dias IS, Cruz N, et al. Design of finasteride-loaded nanoparticles for potential treatment of alopecia. Skin Pharmacol Physiol. 2017;30:197–204.
   PubMed Web of Science ®Google Scholar
• Takeuchi I, Hida Y, Makino K. Minoxidil-encapsulated poly(L-lactide-co-glycolide) nanoparticles with hair follicle delivery properties prepared using W/O/W solvent evaporation and sonication. Biomed Mater Eng. 2018;29:217–228.
   PubMed Web of Science ®Google Scholar
• Matos BN, Reis TA, Gratieri T, et al. Chitosan nanoparticles for targeting and sustaining minoxidil sulphate delivery to hair follicles. Int J Biol Macromol. 2015;75:225–229.
   PubMed Web of Science ®Google Scholar
• Padois K, Cantieni C, Bertholle V, et al. Solid lipid nanoparticles suspension versus commercial solutions for dermal delivery of minoxidil. Int J Pharm. 2011;416:300–304.
   PubMed Web of Science ®Google Scholar
• Gomes MJ, Martins S, Ferreira D, et al. Lipid nanoparticles for topical and transdermal application for alopecia treatment: development, physicochemical characterization, and in vitro release and penetration studies. Int J Nanomedicine. 2014;9:1231–1242.
   PubMed Web of Science ®Google Scholar
• Vincenzi C, Marisaldi B, Tosti A, et al. Effects of a new topical treatment containing several hair growth promoters in women with early female pattern hair loss. Ski Appendage Disord. 2019;5:146–151.
   PubMed Web of Science ®Google Scholar
• Madheswaran T, Baskaran R, Yoo BK, et al. In vitro and in vivo skin distribution of 5alpha-reductase inhibitors loaded into liquid crystalline nanoparticles. J Pharm Sci. 2017;106:3385–3394.
   PubMed Web of Science ®Google Scholar
• Kim JH, Na J, Bak D-H, et al. Development of finasteride polymer microspheres for systemic application in androgenic alopecia. Int J Mol Med. 2019;43:2409–2419.
   PubMed Web of Science ®Google Scholar
• Vincenzi C, Marisaldi B, Tosti A et al., Efficacy and safety of topical finasteride in a new delivery system, poster in WCD 2019
   Google Scholar
• Das L, Kaurav M, Pandey RS. Phospholipid-polymer hybrid nanoparticle-mediated transfollicular delivery of quercetin: prospective implement for the treatment of androgenic alopecia. Drug Dev Ind Pharm. 2019;45:1654–1663.
   PubMed Web of Science ®Google Scholar
• Takabayashi Y, Nambu M, Ishihara M, et al. Enhanced effect of fibroblast growth factor-2-containing dalteparin/protamine nanoparticles on hair growth. Clin Cosmet Investig Dermatol. 2016;9:127–134.
   PubMed Web of Science ®Google Scholar
• Boca S, Berce C, Jurj A, et al. Ruxolitinib-conjugated gold nanoparticles for topical administration: an alternative for treating alopecia?. Med Hypotheses. 2017;109:42–45.
   PubMed Web of Science ®Google Scholar
• Yazdani-Arazi SN, Ghanbarzadeh S, Adibkia K, et al. Histological evaluation of follicular delivery of arginine via nanostructured lipid carriers: a novel potential approach for the treatment of alopecia. Cells Nanomed Biotechnol. 2017;45:1379–1387.
   PubMed Web of Science ®Google Scholar
• Hamishehkar H, Ghanbarzadeh S, Sepehran S, et al. Histological assessment of follicular delivery of flutamide by solid lipid nanoparticles: potential tool for the treatment of androgenic alopecia. Drug Dev Ind Pharm. 2016;42:846–853.
   PubMed Web of Science ®Google Scholar
• Zhou Z, Lenk R, Dellinger A, et al. Fullerene nanomaterials potentiate hair growth. Nanomedicine. 2009;5:202–207.
   PubMed Web of Science ®Google Scholar
• Hatem S, Nasr M, Moftah NH, et al. Melatonin vitamin C-based nanovesicles for treatment of androgenic alopecia: design, characterization and clinical appraisal. Eur J Pharm Sci. Internet. 2018;122:246–253. Elsevier B.V. DOI:10.1016/j.ejps.2018.06.034
   PubMed Web of Science ®Google Scholar
• Gelfuso GM, Barros MADO, Delgado-Charro MB, et al. Iontophoresis of minoxidil sulphate loaded microparticles, a strategy for follicular drug targeting? Colloids Surf B Biointerfaces. Internet. 2015;134:408–412.
   PubMed Web of Science ®Google Scholar
• Kumar P, Singh S, Handa V, et al. Oleic acid nanovesicles of minoxidil for enhanced follicular delivery. Medicines. 2018;5:103.
   Google Scholar
• Aljuffali IA, Pan T-L, Sung CT, et al. Anti-PDGF receptor beta antibody-conjugated squarticles loaded with minoxidil for alopecia treatment by targeting hair follicles and dermal papilla cells. Nanomedicine. 2015;11:1321–1330.
   PubMed Web of Science ®Google Scholar
• Aljuffali IA, Sung CT, Shen F-M, et al. Squarticles as a lipid nanocarrier for delivering diphencyprone and minoxidil to hair follicles and human dermal papilla cells. Aaps J. 2014;16:140–150.
   PubMed Web of Science ®Google Scholar
• Wilson V, Siram K, Rajendran S, et al. Development and evaluation of finasteride loaded ethosomes for targeting to the pilosebaceous unit. Cells Nanomed Biotechnol. 2018;46:1892–1901.
   PubMed Web of Science ®Google Scholar
• Noor NM, Sheikh K, Somavarapu S, et al. Preparation and characterization of dutasteride-loaded nanostructured lipid carriers coated with stearic acid-chitosan oligomer for topical delivery. Eur J Pharm Biopharm. 2017;117:372–384.
   PubMed Web of Science ®Google Scholar
• Angelo T, Barbalho GN, Gelfuso GM, et al. Minoxidil topical treatment may be more efficient if applied on damp scalp in comparison with dry scalp. Dermatol Ther. 2016;29:330–333.
   PubMed Web of Science ®Google Scholar
• Pereira MN, Schulte HL, Duarte N, et al. Solid effervescent formulations as new approach for topical minoxidil delivery. Eur J Pharm Sci. 2017;96:411–419.
   PubMed Web of Science ®Google Scholar
• Tricarico D, Maqoud F, Curci A, et al. Characterization of minoxidil/hydroxypropyl-β-cyclodextrin inclusion complex in aqueous alginate gel useful for alopecia management: efficacy evaluation in male rat. Eur J Pharm Biopharm. Internet. 2018;122:146–157. DOI:10.1016/j.ejpb.2017.10.015
   PubMed Web of Science ®Google Scholar